Introduction
Clearance and subsequent protection against many viral pathogens are often mediated by the effector functions of activated cytolytic CD8 T cells (CTL) capable of antigen-mediated cytokine secretion and directed cytolysis of virally infected cells. Early studies using perforin-deficient mice indicated that upon engagement of the T-cell receptor, activated CTL could trigger apoptosis in target cells through one of two distinct molecular mechanisms (Kagi et al., 1994a (Kagi et al., , 1994b Walsh et al., 1994a Walsh et al., , 1994b : the granule exocytosis pathway involving directed release of cytoplasmic granules containing pore-forming perforin and granzymes into the target cell, or via upregulation of Fas ligand (CD95L), facilitating binding to the Fas receptor (CD95) expressed upon target cells. Initially it was hypothesized that CTL preferentially utilized the perforin/granzyme exocytosis pathway during infection with non-cytolytic viruses, such as during acute LCMV infection in mice. What has become apparent is that CTL have the capability to utilize multiple effector mechanisms to eliminate/control viral infection.
In addition to alternative FasL-mediated cytolysis (Kagi and Hengartner, 1996; Kagi et al., 1995) , secretion of inflammatory cytokines such as IFNγ and TNFα by effector CTL has also been shown to contribute to the protective CD8-mediated immune response, through inhibition of viral protein expression, recruitment of antigen presenting cells (APC), and/or upregulation of MHC expression on the surface of infected cells and APC, resulting in the consequent increased activation of effector CD8 T cells (Guidotti and Chisari, 2001; Harty et al., 2000) . Indeed, during infection with acutely cytopathic viruses -such as vaccinia, vesicular stomatitis virus, Semliki Forest virus or influenza -it has been reported that CTL mediate anti-viral responses through secretion of cytokines, rather than through perforin or FasL/Fas-mediated cytolysis (Kagi and Hengartner, 1996; Kagi et al., 1995) .
In the absence of either, but not both, of the perforin-or FasLmediated cytolytic pathways, effector CTL effectively controlled primary influenza infection (Topham et al., 1997) . Studies in other viral systems have also demonstrated similar cytolytic "flexibility". During the acute phase of Friend virus infection, when virus levels have peaked, perforin and granzymes A and B are utilized by CTL to mediate virus clearance (Zelinskyy et al., 2004) , whereas during a low-level Friend infection, FasL/Fas interactions seem to be required for effective anti-viral CTL responses (Zelinskyy et al., 2007) . Virus clearance during pulmonary infection with murine gammaherpesvirus is also mediated through CTL utilizing perforin-or FasL-mediated cytolysis (Topham et al., 2001; Usherwood et al., 1997) . However, CD8 T-cell clearance of intestinal rotavirus infection in adult mice was shown to be independent of not only perforin or FasL/Fas cytotoxicity, but also secretion of IFNγ (Franco et al., 1997) , suggesting that alternative CTL mechanisms are utilized within the mouse intestine during this viral infection. Thus, virus type, anatomical location of infection, and level of viral infection may be factors that influence the effector mechanisms utilized by CD8 T cells during the anti-viral response.
Interaction between the effector CD8 T-cell receptor (TCR) and an MHC class I molecule complexed with an 8-11 amino acid peptide epitope is required to trigger the cytolytic and/or cytokine-mediated effector mechanisms of CD8 T cells during infection. Historically, peptide epitopes were automatically assumed to be derived from the primary open reading frame of the pathogen's genome, while the rare expression of cryptic epitopes was generally considered to be immunologically insignificant. However, evidence has accumulated demonstrating that CTL are able to recognize and respond to cryptic antigens using a murine model of leukemia (Uenaka et al., 1994) and during infection of mice with influenza (Elliott et al., 1996) . To our knowledge, our lab, utilizing the murine retrovirus LP-BM5, the causative agent of murine AIDS (MAIDS), was the first to define a CD8 CTL-defined major immunodominant cryptic epitope in a retroviral system (Mayrand et al., 1998 (Mayrand et al., , 2000 Schwarz and Green, 1994) . This LP-BM5 cryptic epitope, SYNTGRFPPL, was encoded in an alternative reading frame (ARF) of the retroviral gag gene, apparently by a frameshifting mechanism(s) (Mayrand et al., 1998) . Despite the increasing evidence that cryptic peptide epitopes contribute significantly to effector CTL responses against tumors and viruses (Bain et al., 2004; Basu et al., 2004; Chen et al., 2001 Chen et al., , 2003 Ho and Green, 2006b; Mayrand et al., 1998 Mayrand et al., , 2000 , there is a relative lack of information available detailing the functional features of CTL specific for these unique antigens.
Although CD8 T-cell effector responses appear to be critical for the control of retroviral infections such as HIV-1, it is well documented that recognition of HIV-1 dominant epitopes by epitope-specific CTL drives the generation of virus escape mutants (Borrow et al., 1997; Geels et al., 2003; Goulder et al., 1997 Goulder et al., , 2001a Goulder et al., , 2001b Price et al., 1997) . The ability of retroviruses to escape CD8 T-cell mediated cytotoxicity has made the design of a protective or therapeutic vaccine quite challenging. Cryptic epitopes represent a relatively underappreciated reservoir of immunogenic antigens when considering the design of multi-epitope vaccines that are intended to reinvigorate the protective CD8 CTL response in patients with progressive AIDS (Schirmbeck et al., 2005; Yokomaku et al., 2004) . Indeed, the generation of immunologically relevant cryptic epitopes during natural HIV-1 infection in humans has recently been demonstrated. Following in vitro recognition of synthetic peptides derived from epitopes located within ARFs of the gag, pol, and env genes of HIV-1, CD8 T cells isolated from HIV-1 infected individuals were able to produce IFNγ and were highly lytic towards APC pulsed with the cryptic epitopes, indicating natural in vivo priming to these ARF-encoded determinants (Cardinaud et al., 2004) . Additionally, there was a high degree of intra-and inter-clade conservation of these ARF epitopes amongst various isolates of the HIV-1 virus, demonstrating that functional preservation of the protein encoded by the primary reading frame may ultimately drive the conservation of ARF epitopes within the genome (Cardinaud et al., 2004) .
Similar to CD8 CTL responses in HIV, such CTL-driven immune selection of virus escape mutants has also been observed during infection of primates with SIV (Allen et al., 2000; Barouch et al., 2002; Evans et al., 1999) , and following passage of murine retrovirus LP-BM5 in MAIDS-susceptible B6 mice (Gaur and Green, 2003) . Detailed sequence comparisons of the LP-BM5 BM5eco cloned retroviral genome to its progenitor murine retrovirus revealed amino acid substitutions only in the known H-2 b restricted epitopes, resulting in diminished CD8 T-cell mediated immunity to LP-BM5 in B6 mice (Gaur and Green, 2003) . Further analogous to HIV infection in humans and our system of LP-BM5 infection in mice, significant CD8 effector responses directed against cryptic epitopes in the SIV retroviral infection model have also been reported. Elite (i.e. infrequent) controllers of the SIVmac239 retroviral isolate were found to have dominant CTL responses against a cryptic epitope located within the +2 ORF of the gag gene (Maness et al., 2007) , suggesting that, at least for certain MHC haplotypes, protection against this retrovirusinduced immunodeficiency may require CTL recognition of cryptic ARF antigens. Although studies with HIV and SIV cryptic antigens have provided evidence that CD8 T cells are able to mount dominant effector responses against cryptic antigens, there has been little direct insight into whether these responses result in protection against virusinduced disease. Previously, we have reported that CD8 CTL directed against the cryptic epitope SYNTGRFPPL are sufficient to induce protection in MAIDS-susceptible BALB/c CD8 −/− mice infected with LP-BM5 retrovirus (Ho and Green, 2006b ). This study directly demonstrated that CTL recognition of cryptic epitopes in vivo resulted in protection against retrovirus-induced pathogenesis. Due to the similarities between HIV in humans and the disease manifestations of MAIDS (Jolicoeur, 1991; Liang et al., 1996; Morse et al., 1992) , infection of mice with LP-BM5 represents an opportunity for a detailed and controlled study of these unique CD8 effector T-cell responses. Our goal was to further characterize the molecular mechanism(s) involved in the protective CD8 T-cell response against the ARF epitope SYNTGRFPPL during infection of MAIDS-resistant wild-type (w.t.) BALB/c mice with LP-BM5. This question was approached both by direct infection experiments and by utilizing the previously described adoptive transfer approach that results in essentially full protection against LP-BM5-induced disease when w.t. BALB/c anti-SYNTGRFPPL effector CTL are transferred into MAIDS-susceptible CD8 −/− BALB/c mice (Ho and Green, 2006b ). In particular, we employed donor BALB/ c knockout mice to approach the question of whether the perforin/ granzyme and/or FasL cytolytic pathways, and/or the production of IFNγ, was essential for protection.
Results
Direct infection of mice deficient in perforin results in enhanced susceptibility to LP-BM5 retrovirus
Previously we have shown that resistance to LP-BM5-induced pathogenesis in non-susceptible strains of mice, such as the BALB/c mouse, is mediated by a protective CD8 T-cell response against a cryptic epitope located within ORF2 of the LP-BM5 gag gene, termed SYNTGRFPPL (Ho and Green, 2006b; Mayrand et al., 1998 Mayrand et al., , 2000 Schwarz and Green, 1994) . Conventional effector mechanisms such as perforin-mediated cytotoxicity and secretion of IFNγ are commonly associated with enhancing the protective response during infection of mice with Friend retrovirus (Stromnes et al., 2002; Zelinskyy et al., 2004) and infection of humans with HIV (Benito et al., 2004) . Therefore, we initially used perforin (pfp −/− ), or IFNγ (IFNγ −/− ), deficient mice to determine which effector mechanisms were involved during the CD8-mediated response against the cryptic epitope SYNTGRFPPL during infection with LP-BM5. Activational and immunodeficiency parameters associated with infection were assessed in pfp −/− and IFNγ −/− mice and compared to disease in susceptible BALB/c CD8 −/− mice and resistant BALB/c w.t. mice.
As expected, by measurement of activational parameters such as splenomegaly (P = .0049) and hypergammglobulinemia, with respect to both IgG2A and IgM (P = .0337 and P = .0093 respectively); in addition to measurement of immunodeficiency parameters, such as impaired lymphocyte responsiveness to ConA (P = .0002), CD8
−/− mice infected with LP-BM5 had significantly more disease than non-infected controls (Figs. 1A-C (Giese et al., 1996; Morawetz et al., 1998) . To verify that the lack of disease observed in BALB/c IFNγ −/− mice was not instead due to an IFNγ-dependent pathogenic mechanism, we infected susceptible B6 mice lacking IFNγ with equivalent amounts of LP-BM5 and assessed disease severity, compared to w.t. B6 controls. With this experimental system, we found that IFNγ −/− B6 mice had similar splenomegaly and immunosuppression as compared to infected w.t. B6 controls (Figs. S1A and B). Thus, the absence of disease susceptibility in BALB/c IFNγ −/− mice infected with LP-BM5 suggested that IFNγ may not be required during the protective response against LP-BM5-induced pathogenesis. In contrast, LP-BM5 infection of mice lacking perforin resulted in a significant increase in spleen weight compared to either non-infected pfp −/− controls (P = .033) or to the w.t. BALB/c mice infected with LP-BM5 (P = .0452) (Fig. 1A ). There was a trend towards an increased, although not significantly greater, amount of serum IgG2A in pfp −/− mice infected with LP-BM5 compared to noninfected pfp −/− mice (Fig. 1B) . However, it was clear that the infected pfp −/− mice converted to disease susceptibility based on the hyper Ig criterion, as serum levels of IgM were significantly greater in pfp
infected mice compared to the pfp −/− uninfected controls (P = .0293). Confirming a conversion to disease susceptibility in BALB/c pfp −/− mice, T-cell responsiveness to ConA was significantly reduced (P = .0297) upon infection ( Fig. 1C) , and correspondingly, viral load was significantly increased compared to non-infected controls and both infected IFNγ −/− and w.t. BALB/c mice ( Fig. 1E ).
Overall, summation of all disease parameters into a measurement of disease index clearly indicated that a deficiency in perforin resulted in significantly greater MAIDS disease compared to the disease index of both pfp −/− non-infected controls (P = .0007), and, the disease index of infected w.t. BALB/c mice (P = .0235) (Fig. 1D ). Collectively, these results provide evidence that the ability to express perforin is an important factor in the resistance of w.t. BALB/c mice to LP-BM5-induced pathogenesis and specifically to the spread of retroviral infection.
FasL/Fas-mediated CTL mechanisms do not significantly contribute to the CD8 T-cell response during LP-BM5 infection
Based upon the phenotype of the FasL gld mutation, it is well known that homozygous mutant mice develop enlarged spleens, lymphadenopathy, and systemic autoimmunity, with significant onset of symptoms by 20 weeks of age (Roths et al., 1984) . In agreement with the literature, and, despite evidence of a trend towards elevated SYNTGRFPPL followed by secondary restimulation of splenocytes with synthetic peptide. B: ORF2/SYNTGRFPPL-specific cytotoxicity by the highly lytic ORF2/SYNTGRFPPL-specific CTL clone, D7, and by CTL derived from DG-Vac/SYNGRFPPL stimulated w.t. BALB/c mice. CTL activity was measured against P815B targets incubated with or without the addition of the relatively calcium-specific chelating agent EGTA and MgCL 2 . The data are representative of at least 2 independent experiments. C: Disease index of CD8 −/− recipients receiving adoptive transfer of 1-3 × 10 7 purified naïve CD8 T cells isolated from FasL −/− or w.t. BALB/c mice and infected with LP-BM5. Disease was assessed at 11 weeks post-infection. NS indicates non-significant differences between experimental groups. Students T tests were used to measure disease significance of infected mice in comparison to non-infected controls, or to infected BALB/c mice.
spleen weights and levels of serum IgG2A (Fig. S2) . In sharp contrast, the absence of perforin expression by the effector cells resulted in ablation of target-cell lysis of either the Fas1210 + or Fas1210 − peptide-pulsed targets ( Fig. 2A) . There was, at best, a slight increase in the lysis of Fas1210 + target cells by pfp −/− effector cells, however this lysis did not appear to be peptide specific, as there was no difference in lysis of Fas1210 + targets pulsed with SYNTGRFPPL peptide, compared to the mock pulsed control targets. This apparent perforin-mediated cytolysis was also examined under conditions in which the perforin/granule exocytosis pathway was inhibited by blockade with calcium-specific chelating agent EGTA. Lysis of SYNTGRFRPPL-pulsed P815B target cells by ORF2/ SYNTGRFPPL-specific w.t. polyclonal CTL, and the cell line D7, the highly lytic SYNTGRFPPL-specific CD8 CTL clone derived from polyclonal BALB/c CD8 T-cell effectors of the same specificity (Mayrand et al., 1998) , was nearly abolished when EGTA was added Fig. 3 (continued) .
to the assay mixture (Fig. 2B) , further supporting the preferential use of perforin by protective CTL directed against the cryptic epitope SYNTGRFPPL.
Given the report that there are limitations in utilizing the 51 Cr cytotoxicity assay to examine the FasL/Fas-mediated cytolytic pathways (Liu et al., 2002) and in order to verify the in vitro data, we chose to examine CD8 effector mechanisms with FasL-deficient CTL generated in vivo. In order to diminish the pre-existing systemic lymphoproliferative and immunosuppressive effects of FasL deficiency observed using the direct in vivo infection model, the genetic effect of the FasL mutation was isolated solely to the CD8 compartment. MAIDS-susceptible CD8
− Isolation of effector deficiencies results in the inability of perforin-, but not IFNγ-, deficient effector CD8 T cells to effectively control
LP-BM5-induced pathogenesis
Since direct infection experiments demonstrated that perforindeficient mice are more susceptible to LP-BM5-induced pathogenesis than w.t. BALB/c mice, we wanted to determine whether in vivo disease susceptibility was specifically due to a defect in certain effector-cell functional capabilities by the CD8 T cells specific for ORF2/SYNTGRFPPL. To this end, ORF2/SYNTGRFPPL-restimulated polyclonal effector cells derived from IFNγ −/− or pfp −/− mice previously immunized with Vac-DG were adoptively transferred into LP-BM5-infected CD8 −/− recipients. Prior to transfer, to confirm the functional effector phenotype of transferred CTL, cytolytic capabilities, IFNγ cytokine production, and antigen specificity were assessed. Cytolysis of SYNTGRFPPL-pulsed P815B target cells was demonstrated at high levels by w.t. BALB/c and IFNγ −/− effectors; however, as expected lysis of peptide-pulsed P815B targets was not detected at significant levels using pfp −/− CTL as effectors (Fig. 3A) . Similarly, peptide-specific IFNγ production, while not observed by effectors derived from IFNγ −/− mice, was robust for pfp −/− and w.t. polyclonal effectors (Fig. 3B ). Tetramer staining of the polyclonal effector cells derived from w.t, pfp
−/−
, and IFNγ −/− BALB/c mice indicated that 40-50% of total CD8 T cells were similarly specific for SYNTGRFPPL, irrespective of deficiencies in perforin or IFNγ (Fig. 3C) . As previously described (Ho and Green, 2006b ), both activational and immunodeficiency readouts, measured by spleen weight and mitogen-induced proliferation, respectively, indicated minimal disease in CD8 (Ho and Green, 2006b ) demonstrating that CD8 effector CTL per se were responsible for mediating disease resistance, transfer of purified CD4 T cells by positive selection just prior to transfer (pCD4+) resulted in a similar level of disease, compared to CD8 −/− mice not receiving a transfer. Conversely, purification of CD8 T cells from bulk CTL cultures via either positive selection (pCD8+) or CD4 depletion (CD4p − ), also just prior to transfer, resulted in significant disease protection, similar to the protection observed for the transfer of bulk CTL preparations. Interestingly, the splenomegaly of infected CD8 −/− mice receiving pfp −/− donor cells was less severe compared to control LP-BM5-infected, but non-reconstituted, CD8 −/− mice (P = .02). These data suggested the possibility of one or more residual pfp-independent mechanisms of protection, and/or a differential ability to resolve the level of disease by this, compared to the other, disease parameters. Collectively, these findings suggest that perforin function, specifically by ORF2/SYNTGRFPPL-specific CD8 T cells, is critical for full MAIDS resistance.
Discussion
The essential role of CD8 T cells in protection against MAIDS, based upon CD8 T-cell recognition of a non-traditional cryptic epitope, has been previously demonstrated, as gag-specific CD8 CTL directed against an epitope located within ORF2 of the gag gene are critical for mediating resistance to LP-BM5-induced pathogenesis (Mayrand et al., 2000; Schwarz and Green, 1994) . Reconstitution of disease susceptible BALB/c CD8 −/− mice with CD8 CTL directed against this cryptic epitope restored resistance to virus-induced pathogenesis, including viral immunosuppression (Ho and Green, 2006b) . This essentially complete level of protection was remarkable, considering that the very nature of the generation of cryptic ARF-encoded epitopes may suggest a diminished density of cell surface viral peptide-MHC class I complex presented, in this case, on LP-BM5-infected target cells. Consequently, either a decreased frequency of CD8 CTL capable of recognizing these presumably infrequent antigens, and/or the possibility that CTL generated against these epitopes may have qualitatively and/or quantitatively impaired effector functions, may well limit the effectiveness of CD8-driven anti-ARF epitope immune responses. However, it has been extrapolated that target cells with an average of three epitope-MHC-I complexes expressed upon the surface are sufficient to induce a half-maximal cytolytic response by effector CD8 T cells (Sykulev et al., 1996) , presumably due to the selective expansion of high avidity TCR-bearing CD8 T cells (Zook et al., 2006) . It is tempting to speculate that the dominant CD8 T-cell response against the K d -restricted gag ARF cryptic epitope SYNTGRFPPL arose because of an absence of functional CTL epitopes encoded in the primary retroviral reading frames, due to immune selection against these typical epitopes. Indeed, in the B6 strain, passage of LP-BM5 in vivo has resulted in epitope-crippling mutations in three of four known ORF1 epitopes (Gaur and Green, 2003) . Evolution of CD8 T-cell responses to recognize cryptic ARF epitopes is not uncommon, as a similar effect was observed upon deletion of the major ORF1 CTL determinant in herpes simplex virus, resulting in an overall increase of previously undetectable CD8 T cells specific for cryptic determinants (Wallace et al., 1999) . In this report, we studied BALB/c mice deficient in effector mechanisms associated with CD8 T-cell function, namely the apoptosis-inducing FasL/Fas and perforin/granzyme cytolytic pathways, and the secretion of the anti-viral cytokine IFNγ. The results herein indicate a conventional, albeit selective, engagement of CD8 T-cell protective mechanism(s) in response to a cryptic ARF immunodominant epitope. Direct infection of mice deficient in perforin, FasL, or IFNγ, in addition to experiments involving isolation of effector deficiencies to the CD8 compartment, indicated that perforinmediated cytolysis is the dominant effector mechanism during the CD8-directed protective response against the ARF epitope SYNTGRFPPL. To a lesser degree, our in vivo data suggested that FasL/Fas signaling may contribute slightly to the effector function of protective CD8 T cells during the anti-LP-BM5 response.
Although direct infection of FasL −/− mice with LP-BM5 suggested a trend towards increased disease pathology, the significant disease susceptibility of pfp −/− mice, both by incidence and severity, indicated that a systemic deficiency in perforin results in an enhanced susceptibility to LP-BM5-induced pathogenesis (Figs. 1A-D) . Susceptibility in pfp −/− mice was somewhat variable, as a small proportion of directly infected pfp −/− mice did not appear to display significant MAIDS pathogenesis (Fig. 1A) . Additionally, CD8 −/− mice receiving adoptive transfer of ORF2/SYNTGRFPPL-specific pfp −/− CD8 CTL had significantly less lymphoproliferation, as measured by spleen weight, compared to the highly susceptible CD8 −/− mice infected with LP-BM5 (Fig. 4A) . However, in support of our overall conclusion that perforin-mediated cytolysis is the dominant effector mechanism of CTL directed against the ARF epitope SYNTGRFPPL, this reduced level of protection was not observed for the other disease parameters, whether tested by the adoptive transfer approach (Fig. 4) or the direct infection approach (Fig. 1) . Preferential use of perforin by CTL resulting in incomplete protection from disease, as evidenced by some parameters of pathogenesis, could be due to two possible, nonexclusive mechanisms: 1) disease kinetics of splenomegaly in pfp −/− deficient mice are reduced in comparison to the highly susceptible CD8 −/− deficient mice, and/or 2) SYNTGRFPPL-specific effector CTL are polyfunctional, requiring multiple effector mechanisms to impart full protection from disease in infected mice. Regarding reduced disease kinetics in pfp −/− mice, a previous study examining mechanisms in MAIDS-resistant mice suggested that pfp deficiency in B10.D2 (H-2 d ) mice resulted in susceptibility to LP-BM5-induced pathogenesis: e.g. about 12% developed robust disease by 16 weeks of infection (Tang et al., 1997) . Therefore, the partial susceptibility of pfp −/− mice could putatively depend upon the stage or level of LP-BM5 infection. Similar observations have been made during natural HIV infection in humans (Rehr et al., 2008) or during Friend retroviral infection of mice (Zelinskyy et al., 2004 (Zelinskyy et al., , 2007 . Polyfunctionality of SYNTGRFPPL-specific effector CTL is an additional explanation for this varying level of disease susceptibility in pfp −/− mice. HIV-1 patients receiving antiretroviral therapy had an increase in polyfunctional CD8 T cells that were able to degranulate and secrete IFNγ, TNFα, and IL-2 in response to infection, resulting in further reduced viral loads. In contrast, in patients with high viral loads, or prior to the establishment of antiretroviral therapy, CD8 T cells were dysfunctional with respect to secretion of effector cytokines (Rehr et al., 2008) . During infection of mice with Friend murine retrovirus, depending upon the level of virus replication, perforin/granzymes A and B, or FasL/Fas-mediated cytolysis of target cells was preferentially utilized by CTL to mediate virus clearance (Zelinskyy et al., 2004 (Zelinskyy et al., , 2007 . Polyfunctional effector CD8 T cells have been documented in several other viral systems. Using a murine model of influenza infection, perforin-deficient CD8 T cells were only able to mediate virus clearance in the presence of Fas, demonstrating that both lytic pathways were utilized by CTL during virus clearance (Topham et al., 1997) . Similar findings were described with murine gammaherpesvirus (Topham et al., 2001 ). Alternatively, it is possible that perforinindependent killing of target cells by granzymes A and B might contribute to the variable susceptibility of perforin-deficient mice. Recent studies support this notion, that, in the absence of perforin, granzymes A and B are capable of mediating cytolysis (Gondek et al., 2005; Kurschus et al., 2004; Zelinskyy et al., 2004) . In regards to the role of IFNγ as an important effector mechanism, we have conclusively demonstrated that IFNγ mice. Treatment of B6 mice with neutralizing mAb to IFNγ before and during the period of infection (Uehara et al., 1994) , or utilizing B6 IFNγ −/− mice (Giese et al., 1996) , was reported to significantly delay the progression of some, but not all, parameters of MAIDS. This notion could be extrapolated, albeit with difficulty, to the context herein of CD8 −/− mice receiving IFNγ −/− effector CTL. However, during similar experimental conditions as our direct infection of BALB/c IFNγ −/− mice, we found that infection of B6 IFNγ −/− mice clearly resulted in significant splenomegaly and immunosuppression, comparable to what was observed in w.t. B6 mice (Fig. S1 ). These data demonstrate, that in our infection model of BALB/c-background knockout mouse strains, the lack of disease observed in BALB/c IFNγ −/− mice was not due to an effect that IFNγ had upon LP-BM5 pathogenesis per se, but rather was explained by the observation that adoptively transferred BALB/c IFNγ −/− CD8 T cells could impart disease protection similar to that observed using w.t. BALB/c CTL. This study provides an important insight into the effector mechanisms utilized by protective CTL directed against a cryptic epitope and further underscores the physiological significance of ARF epitopes in disease protection. Collectively, the findings presented herein strongly implicate perforin function, and suggest, to a much lesser degree, FasL function, by SYNTGRFPPL-induced CD8 T cells, are required for full MAIDS resistance. In terms of vaccination strategies utilizing vectors that can translate from cryptic reading frames, knowing the preferential effector mechanisms utilized by CTL to control viral replication is crucial, as inserting additional immunogenic components that result in enhanced and polyfunctional effector activity should result in a multipronged and highly effective attack on virally infected target cells. Due to the genetic constraints associated with encoding multiple proteins critical for viral pathogenesis and replication within overlapping reading frames of a viral genome that is limited in size, retroviruses and many other viruses may have a particularly low tolerance for amino acid sequence variations within embedded cryptic ORF (or conventional ORF1) epitopes in these regions of overlap (Ho and Green, 2006a) . In support of this notion, conservation of cryptic epitopes within the genome of HIV-1 has been demonstrated amongst multiple isolates of circulating virus (Cardinaud et al., 2004) . Thus, cryptic epitopes present an attractive source of additional immunogenic determinants that may be utilized to elicit protective CD8 T-cell responses (Ho and Green, 2006b ) during infection with viruses prone to antigenic variation due to immune selection pressures.
Materials and methods

Mice
Female BALB/c w.t. mice (6-8 weeks old) were purchased from the National Cancer Institute (NCI, Bethesda, MD). Breeding pairs for knockout mice on the BALB/c background were kindly provided as follows: CD8 
Cell lines, viruses, and reagents
The P815B mouse mastocytoma cell line (H-2 d ), provided by J. Bennink (NIH/NIAID, Bethesda, MD), was maintained in RPMI 1640 supplemented with 5% fetal calf serum, 2 mM L-glutamine, 30 μg/ml penicillin, 20 μg/ml streptomycin, and 33 μg/ml gentamicin. The mouse lymphocytic leukemia cell lines L1210Fas − and L1210Fas + were kindly provided by R. Dutton (Trudeau Institute) and maintained in DMEM supplemented with 5% fetal calf serum, 2 mM L-glutamine, 30 μg/ml penicillin, 20 μg/ml streptomycin, and 200 μg/ml gentamicin. The mouse anti-SYNTGRFPPL CTL line, clone D7, was generated as previously described (Mayrand et al., 1998) , maintained by restimulation every two weeks with 10 6 /ml irradiated syngeneic splenocytes (3000 rads), and 10 μg/ml SYNTGRFPPL peptide. The LP-BM5 retroviral isolate, originally provided by J. W. Hartley and H. C. Morse (National Institutes of Health/National Institute of Allergy and Infectious Diseases, Bethesda, MD), was propagated in our laboratory as previously described (Green et al., 2008; Klinken et al., 1988) . Vac-DG, the recombinant vaccinia virus with the gag gene of the LP-BM5 retrovirus inserted, was generated as previously described (Schwarz and Green, 1994 reported (Ho and Green, 2006b ). Briefly, antigen-sensitized splenocytes were isolated approximately 3 weeks post-priming: the mice were sacrificed and splenocytes were collected by homogenization through mesh screens followed by lysis of red blood cells. Splenocytes were cultured in media with .1 μg/ml of SYNTGRFPPL peptide for 6 days. For short-term maintenance of the cultures, splenocytes were carried for an additional 3 days with 5 U/ml of rIL-2 (Cetus Corporation, Everyville, CA). Prior to adoptive transfer into BALB/c CD8 −/− recipients, CTL were characterized for antigen specificity by staining with tetramer. SYNTGRFPPL-specific cytotoxicity and IFNγ production were assessed by using the standard 51 Cr release assay (Schwarz and Green, 1994) , and intracellular cytokine staining, respectively. Three, 6, 9, and 12 days post LP-BM5 infection, 0.8 -1.5 × 10 Chromium release cytotoxicity assays ORF2/SYNTGRFPPL-specific cytolytic activity was determined in a standard 51 Cr release assay using P815B or L1210Fas + or L1210Fas Cr, followed by pulsing cells with or without 100 ng/ml SYNTGRFPPL peptide at 37°C for 30 min in RPMI supplemented with 10% calf serum and 30 μg/ml penicillin, 20 μg/ml streptomycin. Blockade of perforin-mediated cytotoxicity was achieved by incubation of target cells in medium containing 3 mM EGTA. In this case, to promote the interaction of effector T cells with L1210Fas +/− target cells mediated by LFA adhesion molecules, 2 mM MgCL 2 was added to the assay medium during incubation of target cells with effector cells.
Intracellular cytokine stain of IFNγ
ORF2/SYNTGRFPPL-specific CTL were incubated in complete medium plus 1 μg/ml SYNTGRFPPL or control GFNKLRSTL peptides, 10 U/ml rIL-2 and 10 μg/ml brefeldin A for 6 h at 37°C. Cultured cells were subsequently incubated with a monoclonal antibody (mAb) directed against the FcγII/III receptors (2.4G2, BD Pharmingen) for 10 min on ice followed by surface staining with PE Cy-5-conjugated-anti-mouse CD44 (IM7, BD Pharmingen) and FITC-conjugated-antimouse CD8 (53-6.7, BD Pharmingen) for 20 min on ice. Cells were then fixed in a 1% solution of paraformaldehyde for 20 min at room temperature and rendered permeable with buffer containing .5% saponin (Sigma) for 10 min at room temperature. After permeabilization, cells were cytoplasmically stained with PE-conjugated-antimouse IFNγ (XMG1.2, eBioscience) or isotype control mAb for 30 min at room temperature. Stained cells were analyzed on a FACSCalibur flow cytometer using CellQuest software (BD Bioscience).
Tetramer staining ORF2/SYNTGRFPPL-specific CTL were incubated with anti-FcγII/III on ice for 10 min. Cells were then incubated with APC-conjugated K d / SYNTGRFPPL tetramer or control APC-conjugated K d /GFNKLRSTL at room temperature for 1 h, followed by labeling with FITC-anti-CD8α and PE-anti-CD44 for 20 min on ice. Stained cells were then analyzed on a FACSCalibur as previously stated.
LP-BM5 disease measurement
For analysis of LP-BM5-induced lymphoproliferation, spleen weight was determined, and serum, separated from the collected peripheral blood of sacrificed mice, was tested for total levels of IgG2A and IgM in a standard ELISA assay, as previously described in detail (Green et al., 2008; Li and Green, 2006) . Immunodeficiency was measured using Con A and LPS mitogen-induced proliferation assays of isolated splenocytes as previously described (Green et al., 2008; Li and Green, 2006) . For calculation of viral load, mRNA encoding the BM5 defective and ecotropic gag genes was amplified from purified splenic RNA by real-time RT-PCR as previously described (Cook et al., 2003) .
Calculation of disease index
Disease index was determined by calculating the % disease of all experimental mice for each disease parameter (splenomegaly, LPS and ConA mitogen response, and serum levels of IgG2A and IgM). Percent disease was calculated using the formula: ((experimental value − mean value of non-infected controls) / (mean value of LP-BM5-infected controls − mean value of non-infected controls)) × 100. CD8 −/− mice were used as infected and non-infected controls. Mice with 0% or calculated "negative" disease for any one parameter were assigned a value of 0, mice with 1-20% disease were assigned a value of .5, mice with 21-40% disease were assigned a value of 1, mice with 41-60% disease were assigned a value of 2, mice with 61-80% disease were assigned a value of 3, mice with 81-100% disease were assigned a value of 4, and mice with greater than 100% disease were assigned a value of 5. Values for all parameters were combined for each experimental set of mice and graphed.
Statistics
Prism (GraphPad; San Diego, CA) was used for all statistical tests of significance (P values of ≤.05).
